Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Activity Chemical information
Sel. page Common
name
GPCRdb
ID
Reference
ligand
Vendors

Species

Assay
Type

Activity
Type
Activity
Relation
Activity
Value
p-value
(-log)
Fold
selectivity
Tested
GPCRs
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

14434082 83816 None 16 Human Functional pEC50 = 4.8 4.8 -3 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 2 0 4 2.4 O=Cc1ccnc2c1ccc1c(C=O)ccnc12 10.1021/jm301121j
CHEMBL2205801 83816 None 16 Human Functional pEC50 = 4.8 4.8 -3 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 2 0 4 2.4 O=Cc1ccnc2c1ccc1c(C=O)ccnc12 10.1021/jm301121j
14434082 83816 None 16 Human Functional pEC50 = 4.8 4.8 -3 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 2 0 4 2.4 O=Cc1ccnc2c1ccc1c(C=O)ccnc12 10.1021/jm301121j
CHEMBL2205801 83816 None 16 Human Functional pEC50 = 4.8 4.8 -3 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 2 0 4 2.4 O=Cc1ccnc2c1ccc1c(C=O)ccnc12 10.1021/jm301121j
72791 210699 None 48 Human Functional pEC50 = 5.7 5.7 -1 2
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cc2cccnc2c2ncccc12 10.1021/jm301121j
CHEMBL98682 210699 None 48 Human Functional pEC50 = 5.7 5.7 -1 2
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cc2cccnc2c2ncccc12 10.1021/jm301121j
72791 210699 None 48 Human Functional pEC50 = 5.7 5.7 -1 2
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cc2cccnc2c2ncccc12 10.1021/jm301121j
CHEMBL98682 210699 None 48 Human Functional pEC50 = 5.7 5.7 -1 2
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cc2cccnc2c2ncccc12 10.1021/jm301121j
77865 107342 None 51 Human Functional pEC50 = 5.5 5.5 1 2
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 214 0 0 2 3.4 Clc1cc2cccnc2c2ncccc12 10.1021/jm301121j
CHEMBL317115 107342 None 51 Human Functional pEC50 = 5.5 5.5 1 2
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 214 0 0 2 3.4 Clc1cc2cccnc2c2ncccc12 10.1021/jm301121j
14338 4369 None 74 Human Functional pEC50 = 5.5 5.5 3 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
CHEMBL101165 4369 None 74 Human Functional pEC50 = 5.5 5.5 3 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
77865 107342 None 51 Human Functional pEC50 = 5.5 5.5 1 2
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 214 0 0 2 3.4 Clc1cc2cccnc2c2ncccc12 10.1021/jm301121j
CHEMBL317115 107342 None 51 Human Functional pEC50 = 5.5 5.5 1 2
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 214 0 0 2 3.4 Clc1cc2cccnc2c2ncccc12 10.1021/jm301121j
14338 4369 None 74 Human Functional pEC50 = 5.5 5.5 3 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
CHEMBL101165 4369 None 74 Human Functional pEC50 = 5.5 5.5 3 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
667748 83819 None 57 Human Functional pEC50 = 6.4 6.4 3 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
CHEMBL2205805 83819 None 57 Human Functional pEC50 = 6.4 6.4 3 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
12425 6 None 76 Human Functional pEC50 = 5.4 5.4 1 4
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
1318 6 None 76 Human Functional pEC50 = 5.4 5.4 1 4
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
CHEMBL415879 6 None 76 Human Functional pEC50 = 5.4 5.4 1 4
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
DB02365 6 None 76 Human Functional pEC50 = 5.4 5.4 1 4
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
667748 83819 None 57 Human Functional pEC50 = 6.4 6.4 3 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
CHEMBL2205805 83819 None 57 Human Functional pEC50 = 6.4 6.4 3 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
12425 6 None 76 Human Functional pEC50 = 5.4 5.4 1 4
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
1318 6 None 76 Human Functional pEC50 = 5.4 5.4 1 4
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
CHEMBL415879 6 None 76 Human Functional pEC50 = 5.4 5.4 1 4
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
DB02365 6 None 76 Human Functional pEC50 = 5.4 5.4 1 4
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
1474 154488 None 79 Human Functional pEC50 = 4.4 4.4 -1 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
CHEMBL39879 154488 None 79 Human Functional pEC50 = 4.4 4.4 -1 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
1474 154488 None 79 Human Functional pEC50 = 4.4 4.4 -1 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
CHEMBL39879 154488 None 79 Human Functional pEC50 = 4.4 4.4 -1 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
74265 210806 None 69 Human Functional pEC50 = 6.3 6.3 2 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 0 0 2 4.0 Cc1cnc2c(ccc3c(C)c(C)cnc32)c1C 10.1021/jm301121j
CHEMBL99384 210806 None 69 Human Functional pEC50 = 6.3 6.3 2 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 0 0 2 4.0 Cc1cnc2c(ccc3c(C)c(C)cnc32)c1C 10.1021/jm301121j
20445 83820 None 65 Human Functional pEC50 = 5.3 5.3 2 2
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1cccc(-c2cccc(C)n2)n1 10.1021/jm301121j
CHEMBL2205806 83820 None 65 Human Functional pEC50 = 5.3 5.3 2 2
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1cccc(-c2cccc(C)n2)n1 10.1021/jm301121j
70848 209130 None 67 Human Functional pEC50 = 5.3 5.3 5 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
CHEMBL89445 209130 None 67 Human Functional pEC50 = 5.3 5.3 5 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
72792 202179 None 52 Human Functional pEC50 = 6.3 6.3 5 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
CHEMBL593442 202179 None 52 Human Functional pEC50 = 6.3 6.3 5 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
74265 210806 None 69 Human Functional pEC50 = 6.3 6.3 2 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 0 0 2 4.0 Cc1cnc2c(ccc3c(C)c(C)cnc32)c1C 10.1021/jm301121j
CHEMBL99384 210806 None 69 Human Functional pEC50 = 6.3 6.3 2 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 0 0 2 4.0 Cc1cnc2c(ccc3c(C)c(C)cnc32)c1C 10.1021/jm301121j
20445 83820 None 65 Human Functional pEC50 = 5.3 5.3 2 2
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1cccc(-c2cccc(C)n2)n1 10.1021/jm301121j
CHEMBL2205806 83820 None 65 Human Functional pEC50 = 5.3 5.3 2 2
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1cccc(-c2cccc(C)n2)n1 10.1021/jm301121j
2733927 83822 None 59 Human Functional pEC50 = 5.3 5.3 1 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
CHEMBL2205808 83822 None 59 Human Functional pEC50 = 5.3 5.3 1 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
70848 209130 None 67 Human Functional pEC50 = 5.3 5.3 5 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
CHEMBL89445 209130 None 67 Human Functional pEC50 = 5.3 5.3 5 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
72792 202179 None 52 Human Functional pEC50 = 6.3 6.3 5 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
CHEMBL593442 202179 None 52 Human Functional pEC50 = 6.3 6.3 5 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
2733927 83822 None 59 Human Functional pEC50 = 5.3 5.3 1 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
CHEMBL2205808 83822 None 59 Human Functional pEC50 = 5.3 5.3 1 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
15783796 83825 None 0 Human Functional pEC50 = 6.2 6.2 1 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
CHEMBL2205810 83825 None 0 Human Functional pEC50 = 6.2 6.2 1 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
93149 107257 None 55 Human Functional pEC50 = 6.2 6.2 1 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
CHEMBL316589 107257 None 55 Human Functional pEC50 = 6.2 6.2 1 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
12987698 83823 None 3 Human Functional pEC50 = 5.2 5.2 -3 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
CHEMBL2205809 83823 None 3 Human Functional pEC50 = 5.2 5.2 -3 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
15783796 83825 None 0 Human Functional pEC50 = 6.2 6.2 1 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
CHEMBL2205810 83825 None 0 Human Functional pEC50 = 6.2 6.2 1 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
93149 107257 None 55 Human Functional pEC50 = 6.2 6.2 1 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
CHEMBL316589 107257 None 55 Human Functional pEC50 = 6.2 6.2 1 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
12987698 83823 None 3 Human Functional pEC50 = 5.2 5.2 -3 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
CHEMBL2205809 83823 None 3 Human Functional pEC50 = 5.2 5.2 -3 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
15664 83821 None 63 Human Functional pEC50 = 5.1 5.1 -2 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
CHEMBL2205807 83821 None 63 Human Functional pEC50 = 5.1 5.1 -2 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
15664 83821 None 63 Human Functional pEC50 = 5.1 5.1 -2 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
CHEMBL2205807 83821 None 63 Human Functional pEC50 = 5.1 5.1 -2 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
77524 55903 None 56 Human Functional pEC50 = 4.1 4.1 - 1
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 212 0 2 4 2.2 Oc1ccnc2c1ccc1c(O)ccnc12 10.1021/jm301121j
CHEMBL1623498 55903 None 56 Human Functional pEC50 = 4.1 4.1 - 1
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 212 0 2 4 2.2 Oc1ccnc2c1ccc1c(O)ccnc12 10.1021/jm301121j
77524 55903 None 56 Human Functional pEC50 = 4.1 4.1 - 1
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 212 0 2 4 2.2 Oc1ccnc2c1ccc1c(O)ccnc12 10.1021/jm301121j
CHEMBL1623498 55903 None 56 Human Functional pEC50 = 4.1 4.1 - 1
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 212 0 2 4 2.2 Oc1ccnc2c1ccc1c(O)ccnc12 10.1021/jm301121j
10391001 137285 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL374939 137285 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
11541506 76543 None 0 Human Functional pIC50 = 9 9.0 - 1
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 575 9 2 5 5.7 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)C1 10.1021/jm050965z
CHEMBL205993 76543 None 0 Human Functional pIC50 = 9 9.0 - 1
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 575 9 2 5 5.7 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)C1 10.1021/jm050965z
16105860 137290 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 507 8 2 4 4.7 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(CC)cc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL374978 137290 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 507 8 2 4 4.7 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(CC)cc3)c3ccccc23)CC1 10.1021/jm061118e
16105782 82737 None 0 Human Functional pIC50 = 7 7.0 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 482 6 2 6 3.4 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccncc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL217965 82737 None 0 Human Functional pIC50 = 7 7.0 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 482 6 2 6 3.4 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccncc3)c3ccccc23)CC1 10.1021/jm061118e
16112836 93418 None 3 Human Functional pIC50 = 7 7.0 - 1
Antagonist activity at human recombinant CCR8 expressed in Th2 cells assessed as I309 mediated migration by chemotaxis assayAntagonist activity at human recombinant CCR8 expressed in Th2 cells assessed as I309 mediated migration by chemotaxis assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL245568 93418 None 3 Human Functional pIC50 = 7 7.0 - 1
Antagonist activity at human recombinant CCR8 expressed in Th2 cells assessed as I309 mediated migration by chemotaxis assayAntagonist activity at human recombinant CCR8 expressed in Th2 cells assessed as I309 mediated migration by chemotaxis assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439843 91574 None 0 Human Functional pIC50 = 6 6.0 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 426 4 1 4 4.9 O=C1OC(c2ccnc3ccccc23)CN1C1CCN(Cc2cc3ccccc3[nH]2)CC1 10.1016/j.bmcl.2006.12.076
CHEMBL240462 91574 None 0 Human Functional pIC50 = 6 6.0 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 426 4 1 4 4.9 O=C1OC(c2ccnc3ccccc23)CN1C1CCN(Cc2cc3ccccc3[nH]2)CC1 10.1016/j.bmcl.2006.12.076
16105780 84635 None 0 Human Functional pIC50 = 6 6.0 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 481 7 2 6 3.0 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cnccn3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL222112 84635 None 0 Human Functional pIC50 = 6 6.0 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 481 7 2 6 3.0 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cnccn3)c3ccccc23)CC1 10.1021/jm061118e
44598057 199526 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 421 6 0 4 4.6 CC(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm900713y
CHEMBL567419 199526 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 421 6 0 4 4.6 CC(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm900713y
11533398 76013 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 499 8 2 5 4.9 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)CC2)c1 10.1021/jm050965z
CHEMBL205447 76013 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 499 8 2 5 4.9 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)CC2)c1 10.1021/jm050965z
44457090 97715 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 471 6 0 5 5.4 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm900713y
CHEMBL271128 97715 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 471 6 0 5 5.4 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm900713y
11950828 97674 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cc[n+]([O-])cc1)CC2 10.1021/jm070543k
CHEMBL270971 97674 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cc[n+]([O-])cc1)CC2 10.1021/jm070543k
11950828 97674 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cc[n+]([O-])cc1)CC2 10.1021/jm900713y
CHEMBL270971 97674 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cc[n+]([O-])cc1)CC2 10.1021/jm900713y
44457090 97715 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 471 6 0 5 5.4 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm070543k
CHEMBL271128 97715 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 471 6 0 5 5.4 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm070543k
44457009 159100 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 504 6 0 4 6.7 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2ccc(Cl)cc2)CC3)c1 10.1021/jm070543k
CHEMBL409648 159100 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 504 6 0 4 6.7 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2ccc(Cl)cc2)CC3)c1 10.1021/jm070543k
16105857 166297 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 479 7 2 4 4.2 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL426551 166297 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 479 7 2 4 4.2 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
10480554 150303 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 485 5 0 5 5.7 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(Cl)c(Cl)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL395211 150303 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 485 5 0 5 5.7 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(Cl)c(Cl)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439881 93853 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 457 5 0 6 5.1 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6o5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247563 93853 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 457 5 0 6 5.1 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6o5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
10004785 93897 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 467 5 0 5 5.6 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc6ccccc6c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247762 93897 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 467 5 0 5 5.6 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc6ccccc6c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439890 93968 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 447 6 0 6 4.4 COc1ccc(CN2CCC(N3CC(c4ccnc5ccc(OC)cc45)OC3=O)CC2)cc1 10.1016/j.bmcl.2006.12.076
CHEMBL248171 93968 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 447 6 0 6 4.4 COc1ccc(CN2CCC(N3CC(c4ccnc5ccc(OC)cc45)OC3=O)CC2)cc1 10.1016/j.bmcl.2006.12.076
44439886 93929 None 0 Human Functional pIC50 = 4.9 4.9 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 417 5 0 5 4.4 COc1ccc2nccc(C3CN(C4CCN(Cc5ccccc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247964 93929 None 0 Human Functional pIC50 = 4.9 4.9 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 417 5 0 5 4.4 COc1ccc2nccc(C3CN(C4CCN(Cc5ccccc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439895 150554 None 0 Human Functional pIC50 = 4.9 4.9 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 442 5 0 6 4.3 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(C#N)cc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL395423 150554 None 0 Human Functional pIC50 = 4.9 4.9 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 442 5 0 6 4.3 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(C#N)cc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
16065425 199684 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 405 3 0 4 3.9 CC1Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccncc3)CC4)c2O1 10.1021/jm900713y
CHEMBL568296 199684 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 405 3 0 4 3.9 CC1Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccncc3)CC4)c2O1 10.1021/jm900713y
16105885 82805 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 580 11 2 6 5.0 CCN(CC)CCCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL217984 82805 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 580 11 2 6 5.0 CCN(CC)CCCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
44598821 200394 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 472 6 0 6 4.8 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncn1)CC2 10.1021/jm900713y
CHEMBL573216 200394 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 472 6 0 6 4.8 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncn1)CC2 10.1021/jm900713y
44598059 199468 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 442 5 0 5 4.8 O=C(c1ccncn1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm900713y
CHEMBL566974 199468 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 442 5 0 5 4.8 O=C(c1ccncn1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm900713y
44598769 199555 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 422 6 0 5 4.0 CC(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncn1)CC2 10.1021/jm900713y
CHEMBL567620 199555 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 422 6 0 5 4.0 CC(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncn1)CC2 10.1021/jm900713y
16105854 83946 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 485 8 2 4 4.4 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)CC3CCCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL220650 83946 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 485 8 2 4 4.4 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)CC3CCCC3)c3ccccc23)CC1 10.1021/jm061118e
16065428 200314 None 0 Human Functional pIC50 = 5.8 5.8 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 391 3 0 4 3.5 O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc4c3OCC4)CC2)CC1 10.1021/jm900713y
CHEMBL572537 200314 None 0 Human Functional pIC50 = 5.8 5.8 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 391 3 0 4 3.5 O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc4c3OCC4)CC2)CC1 10.1021/jm900713y
16105774 84358 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 535 10 2 4 5.5 CCCCc1ccc(C(=O)Nc2ccc(S(=O)(=O)NC3CCN(C(=O)CCC)CC3)c3ccccc23)cc1 10.1021/jm061118e
CHEMBL221601 84358 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 535 10 2 4 5.5 CCCCc1ccc(C(=O)Nc2ccc(S(=O)(=O)NC3CCN(C(=O)CCC)CC3)c3ccccc23)cc1 10.1021/jm061118e
3384970 161375 None 6 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 432 6 2 4 4.9 COc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)cc1 10.1021/jm061118e
CHEMBL412116 161375 None 6 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 432 6 2 4 4.9 COc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)cc1 10.1021/jm061118e
16105862 83421 None 0 Human Functional pIC50 = 5.8 5.8 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 469 7 2 5 3.8 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccoc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL219432 83421 None 0 Human Functional pIC50 = 5.8 5.8 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 469 7 2 5 3.8 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccoc3)c3ccccc23)CC1 10.1021/jm061118e
44439837 148065 None 0 Human Functional pIC50 = 5.8 5.8 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 430 8 2 5 4.4 COc1ccc2nccc(C3CN(CCCNCc4cc5ccccc5[nH]4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL393411 148065 None 0 Human Functional pIC50 = 5.8 5.8 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 430 8 2 5 4.4 COc1ccc2nccc(C3CN(CCCNCc4cc5ccccc5[nH]4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44457089 97714 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 471 6 0 5 5.4 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccccn1)CC2 10.1021/jm070543k
CHEMBL271127 97714 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 471 6 0 5 5.4 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccccn1)CC2 10.1021/jm070543k
11950826 159282 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 457 5 0 4 4.6 O=C(c1cc[n+]([O-])cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
CHEMBL409849 159282 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 457 5 0 4 4.6 O=C(c1cc[n+]([O-])cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
44456993 97840 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 441 5 0 4 5.4 O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm900713y
CHEMBL271801 97840 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 441 5 0 4 5.4 O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm900713y
44456993 97840 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 441 5 0 4 5.4 O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
CHEMBL271801 97840 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 441 5 0 4 5.4 O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
44598060 199722 None 0 Human Functional pIC50 = 5.7 5.7 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 0 5 4.1 CC1(C)CCc2cc(CN3CCC4(CC3)CCN(C(=O)c3ccncn3)CC4)ccc2O1 10.1021/jm900713y
CHEMBL568503 199722 None 0 Human Functional pIC50 = 5.7 5.7 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 0 5 4.1 CC1(C)CCc2cc(CN3CCC4(CC3)CCN(C(=O)c3ccncn3)CC4)ccc2O1 10.1021/jm900713y
44457046 167431 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
CHEMBL429436 167431 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
44457046 167431 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm900713y
CHEMBL429436 167431 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm900713y
16105772 83405 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 497 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3F)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL219380 83405 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 497 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3F)c3ccccc23)CC1 10.1021/jm061118e
16105819 84524 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 622 9 2 7 4.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN3CC(C)OC(C)C3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL222020 84524 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 622 9 2 7 4.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN3CC(C)OC(C)C3)CC2)c2ccccc12 10.1021/jm061118e
16112836 93418 None 3 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL245568 93418 None 3 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
45483901 199525 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 476 6 1 5 5.1 CCCC1(CC)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1 10.1021/jm900713y
CHEMBL567417 199525 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 476 6 1 5 5.1 CCCC1(CC)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1 10.1021/jm900713y
16064872 199727 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)c2O1 10.1021/jm900713y
CHEMBL568523 199727 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)c2O1 10.1021/jm900713y
44598124 201094 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 470 3 1 5 4.4 CC1(C)Oc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2C1(F)F 10.1021/jm900713y
CHEMBL579072 201094 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 470 3 1 5 4.4 CC1(C)Oc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2C1(F)F 10.1021/jm900713y
45483880 199683 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 476 3 1 5 4.9 CC(C)(C)C1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1 10.1021/jm900713y
CHEMBL568294 199683 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 476 3 1 5 4.9 CC(C)(C)C1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1 10.1021/jm900713y
16105859 84363 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 497 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccc(F)c3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221639 84363 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 497 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccc(F)c3)c3ccccc23)CC1 10.1021/jm061118e
16105864 84398 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 483 7 2 6 2.9 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3nccn3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221842 84398 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 483 7 2 6 2.9 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3nccn3C)c3ccccc23)CC1 10.1021/jm061118e
16105855 83175 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 487 7 2 5 3.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCOCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218209 83175 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 487 7 2 5 3.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCOCC3)c3ccccc23)CC1 10.1021/jm061118e
11584004 140785 None 1 Human Functional pIC50 = 7.7 7.7 - 1
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 489 7 2 4 5.1 O=C(NC1CCN(Cc2cccc(Oc3ccccc3Cl)c2)CC1)C1(c2ccccc2)CCNC1 10.1021/jm050965z
CHEMBL381619 140785 None 1 Human Functional pIC50 = 7.7 7.7 - 1
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 489 7 2 4 5.1 O=C(NC1CCN(Cc2cccc(Oc3ccccc3Cl)c2)CC1)C1(c2ccccc2)CCNC1 10.1021/jm050965z
45483913 199385 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ncccc3N)CC4)c2O1 10.1021/jm900713y
CHEMBL566324 199385 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ncccc3N)CC4)c2O1 10.1021/jm900713y
44598121 199556 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)cccc2O1 10.1021/jm900713y
CHEMBL567627 199556 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)cccc2O1 10.1021/jm900713y
16105777 137046 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 535 7 2 5 5.4 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc4ccccc4s3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL374414 137046 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 535 7 2 5 5.4 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc4ccccc4s3)c3ccccc23)CC1 10.1021/jm061118e
166926318 195613 None 9 Human Functional pIC50 = 7.6 7.6 - 1
Inhibition of CCR8-mediated calcium mobilization transfected in HEK293 cells assessed as CCL1-induced intracellular Ca2+ level by Fluo4 AM dye based assayInhibition of CCR8-mediated calcium mobilization transfected in HEK293 cells assessed as CCL1-induced intracellular Ca2+ level by Fluo4 AM dye based assay
ChEMBL 429 6 2 4 3.6 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)ccc1NC(=O)c1ccccc1C 10.1021/acs.jmedchem.3c00030
CHEMBL5407071 195613 None 9 Human Functional pIC50 = 7.6 7.6 - 1
Inhibition of CCR8-mediated calcium mobilization transfected in HEK293 cells assessed as CCL1-induced intracellular Ca2+ level by Fluo4 AM dye based assayInhibition of CCR8-mediated calcium mobilization transfected in HEK293 cells assessed as CCL1-induced intracellular Ca2+ level by Fluo4 AM dye based assay
ChEMBL 429 6 2 4 3.6 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)ccc1NC(=O)c1ccccc1C 10.1021/acs.jmedchem.3c00030
16105776 137022 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 585 10 2 5 5.7 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(OCc4ccccc4)cc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL374274 137022 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 585 10 2 5 5.7 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(OCc4ccccc4)cc3)c3ccccc23)CC1 10.1021/jm061118e
9911916 91713 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL240848 91713 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
10433657 93930 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 445 7 0 5 4.8 COc1ccc2nccc(C3CN(C4CCN(CCCc5ccccc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247965 93930 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 445 7 0 5 4.8 COc1ccc2nccc(C3CN(C4CCN(CCCc5ccccc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
11842667 161140 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cccc[n+]2[O-])CC3)c1 10.1021/jm070543k
CHEMBL411651 161140 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cccc[n+]2[O-])CC3)c1 10.1021/jm070543k
44456948 160211 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 442 5 0 5 4.8 O=C(c1ccncn1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
CHEMBL410885 160211 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 442 5 0 5 4.8 O=C(c1ccncn1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
44456948 160211 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 442 5 0 5 4.8 O=C(c1ccncn1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm900713y
CHEMBL410885 160211 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 442 5 0 5 4.8 O=C(c1ccncn1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm900713y
16105887 84381 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 640 9 2 6 5.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN3CCc4ccccc4C3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221712 84381 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 640 9 2 6 5.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN3CCc4ccccc4C3)CC2)c2ccccc12 10.1021/jm061118e
16105865 169444 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 494 7 2 5 3.9 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccnc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL441870 169444 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 494 7 2 5 3.9 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccnc3C)c3ccccc23)CC1 10.1021/jm061118e
16065567 201282 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 419 3 0 4 4.3 CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccncc3)CC4)cccc2O1 10.1021/jm900713y
CHEMBL583621 201282 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 419 3 0 4 4.3 CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccncc3)CC4)cccc2O1 10.1021/jm900713y
10479253 91573 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 457 5 1 6 4.3 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2n1 10.1016/j.bmcl.2006.12.076
CHEMBL240461 91573 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 457 5 1 6 4.3 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2n1 10.1016/j.bmcl.2006.12.076
44439883 93896 None 0 Human Functional pIC50 = 5.5 5.5 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 468 5 0 6 5.0 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc6ccccc6n5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247761 93896 None 0 Human Functional pIC50 = 5.5 5.5 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 468 5 0 6 5.0 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc6ccccc6n5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
10412437 151418 None 0 Human Functional pIC50 = 5.5 5.5 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 470 5 0 6 4.9 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6n5C)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL396102 151418 None 0 Human Functional pIC50 = 5.5 5.5 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 470 5 0 6 4.9 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6n5C)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
11951000 97875 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cc[n+]([O-])cc2)CC3)c1 10.1021/jm900713y
CHEMBL272022 97875 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cc[n+]([O-])cc2)CC3)c1 10.1021/jm900713y
44457093 97831 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 441 5 0 4 5.4 O=C(c1ccncc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm070543k
CHEMBL271768 97831 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 441 5 0 4 5.4 O=C(c1ccncc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm070543k
11951000 97875 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cc[n+]([O-])cc2)CC3)c1 10.1021/jm070543k
CHEMBL272022 97875 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cc[n+]([O-])cc2)CC3)c1 10.1021/jm070543k
44457105 158706 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 504 6 0 4 6.7 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc(Cl)cc1)CC2 10.1021/jm070543k
CHEMBL409224 158706 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 504 6 0 4 6.7 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc(Cl)cc1)CC2 10.1021/jm070543k
44457105 158706 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 504 6 0 4 6.7 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc(Cl)cc1)CC2 10.1021/jm900713y
CHEMBL409224 158706 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 504 6 0 4 6.7 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc(Cl)cc1)CC2 10.1021/jm900713y
16105775 83420 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 549 11 2 4 5.9 CCCCCc1ccc(C(=O)Nc2ccc(S(=O)(=O)NC3CCN(C(=O)CCC)CC3)c3ccccc23)cc1 10.1021/jm061118e
CHEMBL219431 83420 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 549 11 2 4 5.9 CCCCCc1ccc(C(=O)Nc2ccc(S(=O)(=O)NC3CCN(C(=O)CCC)CC3)c3ccccc23)cc1 10.1021/jm061118e
16105868 138128 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 471 7 2 4 4.0 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL376517 138128 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 471 7 2 4 4.0 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCCC3)c3ccccc23)CC1 10.1021/jm061118e
16105867 137953 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 443 7 2 4 3.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL376071 137953 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 443 7 2 4 3.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CC3)c3ccccc23)CC1 10.1021/jm061118e
16105863 84365 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 539 7 2 6 4.2 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc(C(C)(C)C)nn3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221650 84365 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 539 7 2 6 4.2 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc(C(C)(C)C)nn3C)c3ccccc23)CC1 10.1021/jm061118e
10003657 152919 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 445 5 0 5 5.0 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(C)c(C)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL397395 152919 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 445 5 0 5 5.0 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(C)c(C)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
11685733 140289 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 589 9 2 5 6.1 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL380492 140289 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 589 9 2 5 6.1 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
16105817 137059 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 578 9 2 6 4.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN3CCCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL374527 137059 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 578 9 2 6 4.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN3CCCC3)CC2)c2ccccc12 10.1021/jm061118e
44598058 200588 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 472 6 0 6 4.8 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2ccncn2)CC3)c1 10.1021/jm900713y
CHEMBL574655 200588 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 472 6 0 6 4.8 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2ccncn2)CC3)c1 10.1021/jm900713y
16105781 83192 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 480 7 2 5 3.6 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccn3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218298 83192 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 480 7 2 5 3.6 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccn3)c3ccccc23)CC1 10.1021/jm061118e
11526626 75569 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 531 8 1 4 6.3 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL204419 75569 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 531 8 1 4 6.3 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
16105779 137288 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 528 7 2 5 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc(C)nc(Cl)c3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL374964 137288 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 528 7 2 5 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc(C)nc(Cl)c3)c3ccccc23)CC1 10.1021/jm061118e
16105778 82629 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 551 7 2 5 5.1 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc(C)oc3C(F)(F)F)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL217909 82629 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 551 7 2 5 5.1 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc(C)oc3C(F)(F)F)c3ccccc23)CC1 10.1021/jm061118e
16105858 84394 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccc(C)c3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221790 84394 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccc(C)c3)c3ccccc23)CC1 10.1021/jm061118e
44598062 199726 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 446 3 1 5 4.4 CC1(C)C=Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)c2O1 10.1021/jm900713y
CHEMBL568522 199726 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 446 3 1 5 4.4 CC1(C)C=Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)c2O1 10.1021/jm900713y
10255258 150556 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 495 5 0 5 5.2 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(Br)cc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL395424 150556 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 495 5 0 5 5.2 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(Br)cc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
16112836 93418 None 3 Human Functional pIC50 = 6.3 6.3 - 1
Antagonist activity at human recombinant CCR8 expressed in HUT78 cells assessed as I309-mediated migration by chemotaxis assayAntagonist activity at human recombinant CCR8 expressed in HUT78 cells assessed as I309-mediated migration by chemotaxis assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL245568 93418 None 3 Human Functional pIC50 = 6.3 6.3 - 1
Antagonist activity at human recombinant CCR8 expressed in HUT78 cells assessed as I309-mediated migration by chemotaxis assayAntagonist activity at human recombinant CCR8 expressed in HUT78 cells assessed as I309-mediated migration by chemotaxis assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
10409369 169608 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 411 8 0 5 4.8 CCCCCCN1CCC(N2CC(c3ccnc4ccc(OC)cc34)OC2=O)CC1 10.1016/j.bmcl.2006.12.076
CHEMBL443315 169608 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 411 8 0 5 4.8 CCCCCCN1CCC(N2CC(c3ccnc4ccc(OC)cc34)OC2=O)CC1 10.1016/j.bmcl.2006.12.076
44598820 201237 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 465 6 0 4 4.8 O=C(c1ccncc1)N1CCC2(CCN(Cc3ccccc3OC(F)(F)C(F)F)CC2)CC1 10.1021/jm900713y
CHEMBL583212 201237 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 465 6 0 4 4.8 O=C(c1ccncc1)N1CCC2(CCN(Cc3ccccc3OC(F)(F)C(F)F)CC2)CC1 10.1021/jm900713y
11965686 201311 None 3 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 487 6 1 5 4.7 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc[nH]c1=O)CC2 10.1021/jm900713y
CHEMBL583843 201311 None 3 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 487 6 1 5 4.7 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc[nH]c1=O)CC2 10.1021/jm900713y
11539239 78155 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 430 8 1 4 4.8 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)Cc3ccccc3)CC2)c1 10.1021/jm050965z
CHEMBL210322 78155 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 430 8 1 4 4.8 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)Cc3ccccc3)CC2)c1 10.1021/jm050965z
11519336 77905 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 527 9 1 5 5.6 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4OC)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL209350 77905 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 527 9 1 5 5.6 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4OC)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
16105783 83243 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 457 7 2 4 3.6 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218554 83243 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 457 7 2 4 3.6 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCC3)c3ccccc23)CC1 10.1021/jm061118e
16105773 84444 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 497 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(F)cc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221978 84444 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 497 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(F)cc3)c3ccccc23)CC1 10.1021/jm061118e
16105784 84354 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 485 7 2 4 4.4 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCCCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221586 84354 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 485 7 2 4 4.4 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCCCC3)c3ccccc23)CC1 10.1021/jm061118e
16065704 201329 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 436 3 1 6 3.7 CC1(C)Oc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)c2O1 10.1021/jm900713y
CHEMBL584087 201329 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 436 3 1 6 3.7 CC1(C)Oc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)c2O1 10.1021/jm900713y
16105861 83191 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 535 7 2 4 5.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(C(C)(C)C)cc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218297 83191 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 535 7 2 4 5.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(C(C)(C)C)cc3)c3ccccc23)CC1 10.1021/jm061118e
16105787 83947 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 473 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)CC(C)(C)C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL220651 83947 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 473 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)CC(C)(C)C)c3ccccc23)CC1 10.1021/jm061118e
10343818 151447 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 451 5 0 5 5.1 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(Cl)cc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL396124 151447 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 451 5 0 5 5.1 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(Cl)cc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439838 91397 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 444 8 1 5 4.7 COc1ccc2nccc(C3CN(CCCN(C)Cc4cc5ccccc5[nH]4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL240249 91397 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 444 8 1 5 4.7 COc1ccc2nccc(C3CN(CCCN(C)Cc4cc5ccccc5[nH]4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439887 93967 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 451 5 0 5 5.1 COc1ccc2nccc(C3CN(C4CCN(Cc5cccc(Cl)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL248169 93967 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 451 5 0 5 5.1 COc1ccc2nccc(C3CN(C4CCN(Cc5cccc(Cl)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439909 167627 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 499 4 0 5 5.3 COc1ccc2nccc(C3CN(C4CCN(C(=O)c5ccc(Cl)c(Cl)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL430012 167627 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 499 4 0 5 5.3 COc1ccc2nccc(C3CN(C4CCN(C(=O)c5ccc(Cl)c(Cl)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
16105786 141794 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 473 9 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C(CC)CC)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL385654 141794 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 473 9 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C(CC)CC)c3ccccc23)CC1 10.1021/jm061118e
16105856 83948 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 521 9 2 4 5.0 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C(CC)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL220652 83948 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 521 9 2 4 5.0 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C(CC)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
44598819 199448 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 419 6 0 4 4.6 C=C(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm900713y
CHEMBL566759 199448 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 419 6 0 4 4.6 C=C(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm900713y
11950827 97673 None 2 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cccc[n+]1[O-])CC2 10.1021/jm070543k
CHEMBL270969 97673 None 2 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cccc[n+]1[O-])CC2 10.1021/jm070543k
10412573 93854 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 473 5 0 6 5.6 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6s5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247564 93854 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 473 5 0 6 5.6 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6s5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439885 93928 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 423 5 0 5 4.8 COc1ccc2nccc(C3CN(C4CCN(CC5CCCCC5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247963 93928 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 423 5 0 5 4.8 COc1ccc2nccc(C3CN(C4CCN(CC5CCCCC5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
16065569 199423 None 28 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1 10.1021/jm900713y
CHEMBL566543 199423 None 28 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1 10.1021/jm900713y
166926318 195613 None 9 Human Functional pIC50 = 8.1 8.1 - 1
Inhibition of CCR8 (unknown origin)-mediated beta-arrestin downstream signalling in CCL1-induced CHO cells assessed as beta-lactamase level by Tango assayInhibition of CCR8 (unknown origin)-mediated beta-arrestin downstream signalling in CCL1-induced CHO cells assessed as beta-lactamase level by Tango assay
ChEMBL 429 6 2 4 3.6 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)ccc1NC(=O)c1ccccc1C 10.1021/acs.jmedchem.3c00030
CHEMBL5407071 195613 None 9 Human Functional pIC50 = 8.1 8.1 - 1
Inhibition of CCR8 (unknown origin)-mediated beta-arrestin downstream signalling in CCL1-induced CHO cells assessed as beta-lactamase level by Tango assayInhibition of CCR8 (unknown origin)-mediated beta-arrestin downstream signalling in CCL1-induced CHO cells assessed as beta-lactamase level by Tango assay
ChEMBL 429 6 2 4 3.6 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)ccc1NC(=O)c1ccccc1C 10.1021/acs.jmedchem.3c00030
11273324 95961 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm070543k
CHEMBL259243 95961 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm070543k
11273324 95961 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm900713y
CHEMBL259243 95961 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm900713y
16105866 83244 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 480 7 2 5 3.6 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccnc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218555 83244 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 480 7 2 5 3.6 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccnc3)c3ccccc23)CC1 10.1021/jm061118e
16105771 84592 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(C)cc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL222062 84592 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(C)cc3)c3ccccc23)CC1 10.1021/jm061118e
16105815 83210 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 552 9 2 6 4.2 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN(C)C)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL218369 83210 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 552 9 2 6 4.2 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN(C)C)CC2)c2ccccc12 10.1021/jm061118e
44598061 199494 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 448 3 1 5 4.3 CC1(C)CCc2cc(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)ccc2O1 10.1021/jm900713y
CHEMBL567202 199494 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 448 3 1 5 4.3 CC1(C)CCc2cc(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)ccc2O1 10.1021/jm900713y
15664 83821 None 63 Human Functional pEC50 = 8.3 8.3 -2 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
Drug Central 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 None
CHEMBL2205807 83821 None 63 Human Functional pEC50 = 8.3 8.3 -2 3
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
Drug Central 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 None
486830 4002 None 0 Human Functional pIC50 = 8.1 8.1 -10 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10419462
768 4002 None 0 Human Functional pIC50 = 8.1 8.1 -10 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10419462
812 823 None 0 Human Functional pIC50 = 9.2 9.2 - 1
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10419462
812 823 None 0 Human Functional pIC50 = 9.2 9.2 - 1
UnclassifiedUnclassified
Guide to Pharmacology None None None None 11154210
812 823 None 0 Human Functional pIC50 = 9.2 9.2 - 1
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16221874
815 4001 None 0 Human Functional pIC50 = 9.4 9.4 - 1
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10419462
815 4001 None 0 Human Functional pIC50 = 9.4 9.4 - 1
UnclassifiedUnclassified
Guide to Pharmacology None None None None 11154210
816 4000 None 0 Human Functional pIC50 = 9.4 9.4 - 1
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10419462
11688990 4147 None 0 Human Functional pIC50 None 5.7 5.7 - 1
UnclassifiedUnclassified
Guide to Pharmacology 356 9 1 5 2.6 OCCOCCN1CCN(CC1)Cc1cccc(c1)Oc1ccccc1 16221874
813 4147 None 0 Human Functional pIC50 None 5.7 5.7 - 1
UnclassifiedUnclassified
Guide to Pharmacology 356 9 1 5 2.6 OCCOCCN1CCN(CC1)Cc1cccc(c1)Oc1ccccc1 16221874
CHEMBL1883966 4147 None 0 Human Functional pIC50 None 5.7 5.7 - 1
UnclassifiedUnclassified
Guide to Pharmacology 356 9 1 5 2.6 OCCOCCN1CCN(CC1)Cc1cccc(c1)Oc1ccccc1 16221874




Ligands (move mouse cursor over ligand name to see structure) Receptor Activity Chemical information
Sel. page Common
name
GPCRdb
ID
Reference
ligand
Vendors

Species

Assay
Type
Activity
Type
Activity
Relation
Activity
Value
p-value
(-log)
Fold
selectivity
Tested
GPCRs
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

163322187 196450 None 10 Human Binding pIC50 = 9 9.0 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 463 6 2 4 4.2 Cc1ccccc1C(=O)Nc1c(C)cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)cc1Cl 10.1021/acs.jmedchem.3c00030
CHEMBL5424187 196450 None 10 Human Binding pIC50 = 9 9.0 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 463 6 2 4 4.2 Cc1ccccc1C(=O)Nc1c(C)cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)cc1Cl 10.1021/acs.jmedchem.3c00030
172445647 195486 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 465 6 2 4 4.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)c2ccccc12 10.1021/acs.jmedchem.3c00030
CHEMBL5404620 195486 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 465 6 2 4 4.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)c2ccccc12 10.1021/acs.jmedchem.3c00030
167339834 195156 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 463 6 2 4 4.2 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)ccc1NC(=O)c1cccc(Cl)c1C 10.1021/acs.jmedchem.3c00030
CHEMBL5397693 195156 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 463 6 2 4 4.2 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)ccc1NC(=O)c1cccc(Cl)c1C 10.1021/acs.jmedchem.3c00030
167339722 195818 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 463 6 2 4 4.2 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)ccc1NC(=O)c1ccc(Cl)cc1C 10.1021/acs.jmedchem.3c00030
CHEMBL5411391 195818 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 463 6 2 4 4.2 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)ccc1NC(=O)c1ccc(Cl)cc1C 10.1021/acs.jmedchem.3c00030
167339983 195897 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 463 6 2 4 4.2 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)ccc1NC(=O)c1cc(Cl)ccc1C 10.1021/acs.jmedchem.3c00030
CHEMBL5412884 195897 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 463 6 2 4 4.2 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)ccc1NC(=O)c1cc(Cl)ccc1C 10.1021/acs.jmedchem.3c00030
91032188 193653 None 19 Human Binding pIC50 = 8 8.0 - 0
Inhibition of CCR8 mutant (unknown origin)Inhibition of CCR8 mutant (unknown origin)
ChEMBL 471 8 1 5 4.5 COc1ccccc1Oc1cccc(CN2CCC3(CC2)C(=O)NCN3CCc2ccccc2)c1 10.1021/acs.jmedchem.6b01309
CHEMBL5268017 193653 None 19 Human Binding pIC50 = 8 8.0 - 0
Inhibition of CCR8 mutant (unknown origin)Inhibition of CCR8 mutant (unknown origin)
ChEMBL 471 8 1 5 4.5 COc1ccccc1Oc1cccc(CN2CCC3(CC2)C(=O)NCN3CCc2ccccc2)c1 10.1021/acs.jmedchem.6b01309
60016664 194059 None 0 Human Binding pIC50 = 8 8.0 - 0
Inhibition of CCR8 mutant (unknown origin)Inhibition of CCR8 mutant (unknown origin)
ChEMBL 527 11 1 5 5.8 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C(CCN3CCCC3)c3ccccc3)CC2)c1 10.1021/acs.jmedchem.6b01309
CHEMBL5277802 194059 None 0 Human Binding pIC50 = 8 8.0 - 0
Inhibition of CCR8 mutant (unknown origin)Inhibition of CCR8 mutant (unknown origin)
ChEMBL 527 11 1 5 5.8 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C(CCN3CCCC3)c3ccccc3)CC2)c1 10.1021/acs.jmedchem.6b01309
166926303 196807 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 451 6 3 4 4.1 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC(C)C2CCCNC2)c2ccccc12 10.1021/acs.jmedchem.3c00030
CHEMBL5432566 196807 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 451 6 3 4 4.1 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC(C)C2CCCNC2)c2ccccc12 10.1021/acs.jmedchem.3c00030
167339714 197032 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 487 8 2 6 3.1 COC(=O)CN1CCC([C@@H](C)NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c(C)c2)CC1 10.1021/acs.jmedchem.3c00030
CHEMBL5437230 197032 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 487 8 2 6 3.1 COC(=O)CN1CCC([C@@H](C)NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c(C)c2)CC1 10.1021/acs.jmedchem.3c00030
167339681 195313 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 443 7 2 4 3.8 CCc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)ccc1NC(=O)c1ccccc1C 10.1021/acs.jmedchem.3c00030
CHEMBL5400674 195313 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 443 7 2 4 3.8 CCc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)ccc1NC(=O)c1ccccc1C 10.1021/acs.jmedchem.3c00030
167339838 195319 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 451 6 3 4 4.1 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)N[C@H](C)C2CCNCC2)c2ccccc12 10.1021/acs.jmedchem.3c00030
CHEMBL5400852 195319 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 451 6 3 4 4.1 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)N[C@H](C)C2CCNCC2)c2ccccc12 10.1021/acs.jmedchem.3c00030
60016619 193840 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of CCR8 mutant (unknown origin)Inhibition of CCR8 mutant (unknown origin)
ChEMBL 526 10 2 7 4.3 CCNS(=O)(=O)c1ccc(OC)cc1C1(O)CCN(Cc2cccc(Oc3ccccc3OC)c2)CC1 10.1021/acs.jmedchem.6b01309
CHEMBL5272687 193840 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of CCR8 mutant (unknown origin)Inhibition of CCR8 mutant (unknown origin)
ChEMBL 526 10 2 7 4.3 CCNS(=O)(=O)c1ccc(OC)cc1C1(O)CCN(Cc2cccc(Oc3ccccc3OC)c2)CC1 10.1021/acs.jmedchem.6b01309
172465785 196955 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 463 6 2 4 4.2 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)c(Cl)c1C 10.1021/acs.jmedchem.3c00030
CHEMBL5435573 196955 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 463 6 2 4 4.2 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)c(Cl)c1C 10.1021/acs.jmedchem.3c00030
167339843 194979 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 486 8 3 5 2.7 CNC(=O)CN1CCC([C@@H](C)NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c(C)c2)CC1 10.1021/acs.jmedchem.3c00030
CHEMBL5394357 194979 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 486 8 3 5 2.7 CNC(=O)CN1CCC([C@@H](C)NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c(C)c2)CC1 10.1021/acs.jmedchem.3c00030
166926318 195613 None 9 Human Binding pIC50 = 7.6 7.6 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 429 6 2 4 3.6 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)ccc1NC(=O)c1ccccc1C 10.1021/acs.jmedchem.3c00030
CHEMBL5407071 195613 None 9 Human Binding pIC50 = 7.6 7.6 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 429 6 2 4 3.6 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)ccc1NC(=O)c1ccccc1C 10.1021/acs.jmedchem.3c00030
167339691 196801 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 415 6 2 4 3.2 Cc1cc(S(=O)(=O)NCC2CCN(C)CC2)ccc1NC(=O)c1ccccc1C 10.1021/acs.jmedchem.3c00030
CHEMBL5432453 196801 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 415 6 2 4 3.2 Cc1cc(S(=O)(=O)NCC2CCN(C)CC2)ccc1NC(=O)c1ccccc1C 10.1021/acs.jmedchem.3c00030
167339944 196917 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 457 8 2 4 4.3 CCCN1CCC([C@@H](C)NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c(C)c2)CC1 10.1021/acs.jmedchem.3c00030
CHEMBL5434812 196917 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 457 8 2 4 4.3 CCCN1CCC([C@@H](C)NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c(C)c2)CC1 10.1021/acs.jmedchem.3c00030
167339894 195283 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 449 6 2 4 3.9 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)cc1Cl 10.1021/acs.jmedchem.3c00030
CHEMBL5400080 195283 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 449 6 2 4 3.9 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)cc1Cl 10.1021/acs.jmedchem.3c00030
167339899 195872 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 435 6 2 4 3.9 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)ccc1NC(=O)C1CCCCCC1 10.1021/acs.jmedchem.3c00030
CHEMBL5412408 195872 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 435 6 2 4 3.9 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)ccc1NC(=O)C1CCCCCC1 10.1021/acs.jmedchem.3c00030
166926032 195241 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 451 6 3 4 4.1 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC(C)C2CCNCC2)c2ccccc12 10.1021/acs.jmedchem.3c00030
CHEMBL5399315 195241 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 451 6 3 4 4.1 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC(C)C2CCNCC2)c2ccccc12 10.1021/acs.jmedchem.3c00030
172457962 196476 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 477 6 2 4 4.6 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)N[C@H](C)C23CCN(CC2)CC3)c2ccccc12 10.1021/acs.jmedchem.3c00030
CHEMBL5424675 196476 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 477 6 2 4 4.6 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)N[C@H](C)C23CCN(CC2)CC3)c2ccccc12 10.1021/acs.jmedchem.3c00030
60016473 193727 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of CCR8 mutant (unknown origin)Inhibition of CCR8 mutant (unknown origin)
ChEMBL 433 7 2 5 4.7 COc1ccccc1Oc1cccc(CN2CCC(O)(c3ccccc3C(=O)O)CC2)c1 10.1021/acs.jmedchem.6b01309
CHEMBL5270110 193727 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of CCR8 mutant (unknown origin)Inhibition of CCR8 mutant (unknown origin)
ChEMBL 433 7 2 5 4.7 COc1ccccc1Oc1cccc(CN2CCC(O)(c3ccccc3C(=O)O)CC2)c1 10.1021/acs.jmedchem.6b01309
167339928 195750 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 435 6 2 5 3.6 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)ccc1NC(=O)c1ccsc1C 10.1021/acs.jmedchem.3c00030
CHEMBL5410064 195750 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 435 6 2 5 3.6 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)ccc1NC(=O)c1ccsc1C 10.1021/acs.jmedchem.3c00030
167529305 197035 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 440 6 2 5 3.1 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)cc1C#N 10.1021/acs.jmedchem.3c00030
CHEMBL5437244 197035 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 440 6 2 5 3.1 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)cc1C#N 10.1021/acs.jmedchem.3c00030
166926318 195613 None 9 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of CCR8-mediated cell migration in CCL1-induced human PBMC preincubated for 1 hr followed by CCL1 addition measured after 4 hrs by cell counting methodInhibition of CCR8-mediated cell migration in CCL1-induced human PBMC preincubated for 1 hr followed by CCL1 addition measured after 4 hrs by cell counting method
ChEMBL 429 6 2 4 3.6 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)ccc1NC(=O)c1ccccc1C 10.1021/acs.jmedchem.3c00030
CHEMBL5407071 195613 None 9 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of CCR8-mediated cell migration in CCL1-induced human PBMC preincubated for 1 hr followed by CCL1 addition measured after 4 hrs by cell counting methodInhibition of CCR8-mediated cell migration in CCL1-induced human PBMC preincubated for 1 hr followed by CCL1 addition measured after 4 hrs by cell counting method
ChEMBL 429 6 2 4 3.6 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)ccc1NC(=O)c1ccccc1C 10.1021/acs.jmedchem.3c00030
167339720 195392 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 463 6 2 4 4.2 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)ccc1NC(=O)c1c(C)cccc1Cl 10.1021/acs.jmedchem.3c00030
CHEMBL5402712 195392 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 463 6 2 4 4.2 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)ccc1NC(=O)c1c(C)cccc1Cl 10.1021/acs.jmedchem.3c00030
16105824 84304 None 0 Human Binding pIC50 = 8.4 8.4 - 1
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 549 5 2 5 3.5 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCN(C)CC3)CC2)c2ccccc12 10.1021/acs.jmedchem.3c00030
CHEMBL221251 84304 None 0 Human Binding pIC50 = 8.4 8.4 - 1
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 549 5 2 5 3.5 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCN(C)CC3)CC2)c2ccccc12 10.1021/acs.jmedchem.3c00030
167340022 195278 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 443 6 2 4 3.9 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)c(C)cc1NC(=O)c1ccccc1C 10.1021/acs.jmedchem.3c00030
CHEMBL5399936 195278 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 443 6 2 4 3.9 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)c(C)cc1NC(=O)c1ccccc1C 10.1021/acs.jmedchem.3c00030
166925926 195130 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 483 6 2 4 4.3 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)ccc1NC(=O)c1ccccc1C(F)(F)F 10.1021/acs.jmedchem.3c00030
CHEMBL5397155 195130 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 483 6 2 4 4.3 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)ccc1NC(=O)c1ccccc1C(F)(F)F 10.1021/acs.jmedchem.3c00030
60016644 193875 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Inhibition of CCR8 mutant (unknown origin)Inhibition of CCR8 mutant (unknown origin)
ChEMBL 485 7 2 5 4.7 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3CC(=O)Nc4ccccc43)CC2)c1 10.1021/acs.jmedchem.6b01309
CHEMBL5273480 193875 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Inhibition of CCR8 mutant (unknown origin)Inhibition of CCR8 mutant (unknown origin)
ChEMBL 485 7 2 5 4.7 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3CC(=O)Nc4ccccc43)CC2)c1 10.1021/acs.jmedchem.6b01309
166926335 196047 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 521 8 2 4 5.1 CCCC(=O)N1CCCC(C(C)NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)C1 10.1021/acs.jmedchem.3c00030
CHEMBL5415778 196047 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 521 8 2 4 5.1 CCCC(=O)N1CCCC(C(C)NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)C1 10.1021/acs.jmedchem.3c00030
155557362 174747 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Antagonist activity at human CCR8 expressed in CHOK1 cells assessed as reduction in CCL1-induced beta-arrestin 2 recruitment incubated for 30 mins followed by CCL1 addition and measured after 90 or 180 mins by pathhunter beta-arrestin assayAntagonist activity at human CCR8 expressed in CHOK1 cells assessed as reduction in CCL1-induced beta-arrestin 2 recruitment incubated for 30 mins followed by CCL1 addition and measured after 90 or 180 mins by pathhunter beta-arrestin assay
ChEMBL 560 6 1 6 5.4 CC[C@]12C=C(C(=O)OC)n3c(c(CCNC(=O)c4ccc(Br)cc4)c4ccccc43)[C@H]1N(C#N)CCC2 10.1021/acs.jmedchem.9b01924
CHEMBL4558185 174747 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Antagonist activity at human CCR8 expressed in CHOK1 cells assessed as reduction in CCL1-induced beta-arrestin 2 recruitment incubated for 30 mins followed by CCL1 addition and measured after 90 or 180 mins by pathhunter beta-arrestin assayAntagonist activity at human CCR8 expressed in CHOK1 cells assessed as reduction in CCL1-induced beta-arrestin 2 recruitment incubated for 30 mins followed by CCL1 addition and measured after 90 or 180 mins by pathhunter beta-arrestin assay
ChEMBL 560 6 1 6 5.4 CC[C@]12C=C(C(=O)OC)n3c(c(CCNC(=O)c4ccc(Br)cc4)c4ccccc43)[C@H]1N(C#N)CCC2 10.1021/acs.jmedchem.9b01924
167339879 195469 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 447 6 2 4 3.7 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)c(F)cc1NC(=O)c1ccccc1C 10.1021/acs.jmedchem.3c00030
CHEMBL5404280 195469 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 447 6 2 4 3.7 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)c(F)cc1NC(=O)c1ccccc1C 10.1021/acs.jmedchem.3c00030
166926153 195857 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 463 6 2 4 4.2 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)c(Cl)cc1NC(=O)c1ccccc1C 10.1021/acs.jmedchem.3c00030
CHEMBL5412094 195857 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 463 6 2 4 4.2 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)c(Cl)cc1NC(=O)c1ccccc1C 10.1021/acs.jmedchem.3c00030
132072454 179830 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Antagonist activity at human CCR8 expressed in CHO-K1 cells by PathHunter beta-arrestin assayAntagonist activity at human CCR8 expressed in CHO-K1 cells by PathHunter beta-arrestin assay
ChEMBL 558 6 2 8 4.7 COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN(C#N)[C@H](c3[nH]c4ccccc4c3CCn3cc(-c4cccc(Cl)c4)nn3)C[C@@H]21 10.1016/j.bmc.2020.115546
CHEMBL4744046 179830 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Antagonist activity at human CCR8 expressed in CHO-K1 cells by PathHunter beta-arrestin assayAntagonist activity at human CCR8 expressed in CHO-K1 cells by PathHunter beta-arrestin assay
ChEMBL 558 6 2 8 4.7 COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN(C#N)[C@H](c3[nH]c4ccccc4c3CCn3cc(-c4cccc(Cl)c4)nn3)C[C@@H]21 10.1016/j.bmc.2020.115546
167339914 196028 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 431 7 3 5 2.9 COc1ccccc1C(=O)Nc1ccc(S(=O)(=O)N[C@H](C)C2CCNCC2)cc1C 10.1021/acs.jmedchem.3c00030
CHEMBL5415309 196028 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 431 7 3 5 2.9 COc1ccccc1C(=O)Nc1ccc(S(=O)(=O)N[C@H](C)C2CCNCC2)cc1C 10.1021/acs.jmedchem.3c00030
167339969 196880 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 473 9 2 5 3.6 COCCN1CCC([C@@H](C)NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c(C)c2)CC1 10.1021/acs.jmedchem.3c00030
CHEMBL5434069 196880 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 473 9 2 5 3.6 COCCN1CCC([C@@H](C)NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c(C)c2)CC1 10.1021/acs.jmedchem.3c00030
166926273 195066 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 437 6 3 4 3.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC(C)C2CCNC2)c2ccccc12 10.1021/acs.jmedchem.3c00030
CHEMBL5395905 195066 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 437 6 3 4 3.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC(C)C2CCNC2)c2ccccc12 10.1021/acs.jmedchem.3c00030
172461910 196786 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 455 7 2 4 4.0 Cc1cc(S(=O)(=O)N[C@H](C2CC2)C2CCN(C)CC2)ccc1NC(=O)c1ccccc1C 10.1021/acs.jmedchem.3c00030
CHEMBL5432261 196786 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 455 7 2 4 4.0 Cc1cc(S(=O)(=O)N[C@H](C2CC2)C2CCN(C)CC2)ccc1NC(=O)c1ccccc1C 10.1021/acs.jmedchem.3c00030
167339997 197111 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 471 7 2 5 3.3 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C3COC3)CC2)ccc1NC(=O)c1ccccc1C 10.1021/acs.jmedchem.3c00030
CHEMBL5438933 197111 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Antagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assayAntagonist activity against CCR8 (unknown origin) expressed in CHO-K1 cells preincubated for 1 hr followed by CCL1 addition measured after 24 hrs by ONE-Glo assay
ChEMBL 471 7 2 5 3.3 Cc1cc(S(=O)(=O)N[C@H](C)C2CCN(C3COC3)CC2)ccc1NC(=O)c1ccccc1C 10.1021/acs.jmedchem.3c00030
10367938 83211 None 0 Human Binding pKi = 9.8 9.8 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 2 5 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218374 83211 None 0 Human Binding pKi = 9.8 9.8 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 2 5 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
10391001 137285 None 0 Human Binding pKi = 9.5 9.5 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL374939 137285 None 0 Human Binding pKi = 9.5 9.5 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
11754900 84400 None 0 Human Binding pKi = 9.2 9.2 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 480 5 3 4 3.5 CNC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221865 84400 None 0 Human Binding pKi = 9.2 9.2 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 480 5 3 4 3.5 CNC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
10006907 141901 None 0 Human Binding pKi = 9.2 9.2 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 520 6 3 5 3.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)[C@@H]3CCCN3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL386308 141901 None 0 Human Binding pKi = 9.2 9.2 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 520 6 3 5 3.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)[C@@H]3CCCN3)CC2)c2ccccc12 10.1021/jm061118e
10006907 141901 None 0 Human Binding pKi = 9 9.0 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 520 6 3 5 3.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)[C@@H]3CCCN3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL386308 141901 None 0 Human Binding pKi = 9 9.0 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 520 6 3 5 3.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)[C@@H]3CCCN3)CC2)c2ccccc12 10.1021/jm061118e
9984180 136636 None 0 Human Binding pKi = 9.0 9.0 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 520 5 2 4 4.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL373739 136636 None 0 Human Binding pKi = 9.0 9.0 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 520 5 2 4 4.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCCC3)CC2)c2ccccc12 10.1021/jm061118e
16105811 137756 None 0 Human Binding pKi = 8.8 8.8 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 506 6 3 5 2.9 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C3CNC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL375854 137756 None 0 Human Binding pKi = 8.8 8.8 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 506 6 3 5 2.9 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C3CNC3)CC2)c2ccccc12 10.1021/jm061118e
16105788 83212 None 11 Human Binding pKi = 8.8 8.8 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 6 2 5 4.3 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218375 83212 None 11 Human Binding pKi = 8.8 8.8 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 6 2 5 4.3 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
16105880 84402 None 0 Human Binding pKi = 8.8 8.8 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 508 8 3 5 3.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCCN)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221867 84402 None 0 Human Binding pKi = 8.8 8.8 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 508 8 3 5 3.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCCN)CC2)c2ccccc12 10.1021/jm061118e
16105822 138246 None 0 Human Binding pKi = 8.8 8.8 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 494 5 2 4 3.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N(C)C)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL376910 138246 None 0 Human Binding pKi = 8.8 8.8 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 494 5 2 4 3.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N(C)C)CC2)c2ccccc12 10.1021/jm061118e
16105890 142033 None 0 Human Binding pKi = 7.0 7.0 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 542 6 3 4 5.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)Nc3ccccc3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL387161 142033 None 0 Human Binding pKi = 7.0 7.0 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 542 6 3 4 5.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)Nc3ccccc3)CC2)c2ccccc12 10.1021/jm061118e
11519336 77905 None 0 Human Binding pKi = 8.0 8.0 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 527 9 1 5 5.6 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4OC)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL209350 77905 None 0 Human Binding pKi = 8.0 8.0 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 527 9 1 5 5.6 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4OC)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
16105807 84006 None 0 Human Binding pKi = 8.0 8.0 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 494 7 3 5 3.0 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCN)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL220703 84006 None 0 Human Binding pKi = 8.0 8.0 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 494 7 3 5 3.0 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCN)CC2)c2ccccc12 10.1021/jm061118e
16105813 84279 None 0 Human Binding pKi = 6.9 6.9 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 570 7 2 5 5.1 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)c3ccc(N(C)C)cc3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221078 84279 None 0 Human Binding pKi = 6.9 6.9 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 570 7 2 5 5.1 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)c3ccc(N(C)C)cc3)CC2)c2ccccc12 10.1021/jm061118e
16105831 83446 None 0 Human Binding pKi = 6.9 6.9 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 488 5 2 5 3.8 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)N3CCCCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL219589 83446 None 0 Human Binding pKi = 6.9 6.9 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 488 5 2 5 3.8 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)N3CCCCC3)c3ccccc23)CC1 10.1021/jm061118e
11502217 76062 None 0 Human Binding pKi = 5.9 5.9 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 400 7 1 3 4.8 O=C(Cc1ccccc1)NC1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
CHEMBL205692 76062 None 0 Human Binding pKi = 5.9 5.9 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 400 7 1 3 4.8 O=C(Cc1ccccc1)NC1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
11526626 75569 None 0 Human Binding pKi = 7.8 7.8 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 531 8 1 4 6.3 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL204419 75569 None 0 Human Binding pKi = 7.8 7.8 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 531 8 1 4 6.3 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
16105760 137954 None 0 Human Binding pKi = 7.8 7.8 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 509 5 2 5 4.8 CC(C)(C)OC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL376076 137954 None 0 Human Binding pKi = 7.8 7.8 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 509 5 2 5 4.8 CC(C)(C)OC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
16105805 84438 None 0 Human Binding pKi = 7.8 7.8 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 7 2 5 3.3 COCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221961 84438 None 0 Human Binding pKi = 7.8 7.8 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 7 2 5 3.3 COCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
16105799 166241 None 0 Human Binding pKi = 7.8 7.8 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 482 6 1 6 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(OC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL426207 166241 None 0 Human Binding pKi = 7.8 7.8 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 482 6 1 6 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(OC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
11774008 84633 None 0 Human Binding pKi = 5.8 5.8 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 402 5 2 3 4.9 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2)c2ccccc12)c1ccccc1 10.1021/jm061118e
CHEMBL222110 84633 None 0 Human Binding pKi = 5.8 5.8 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 402 5 2 3 4.9 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2)c2ccccc12)c1ccccc1 10.1021/jm061118e
16105809 84362 None 0 Human Binding pKi = 6.7 6.7 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 522 9 3 5 3.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCCCN)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221638 84362 None 0 Human Binding pKi = 6.7 6.7 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 522 9 3 5 3.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCCCN)CC2)c2ccccc12 10.1021/jm061118e
16105889 84005 None 0 Human Binding pKi = 8.7 8.7 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 494 6 3 4 3.9 CCNC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL220701 84005 None 0 Human Binding pKi = 8.7 8.7 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 494 6 3 4 3.9 CCNC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
9982672 82857 None 0 Human Binding pKi = 8.6 8.6 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 2 5 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2cccc3c(NC(=O)c4ccccc4)cccc23)CC1 10.1021/jm061118e
CHEMBL218037 82857 None 0 Human Binding pKi = 8.6 8.6 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 2 5 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2cccc3c(NC(=O)c4ccccc4)cccc23)CC1 10.1021/jm061118e
16105802 84099 None 0 Human Binding pKi = 8.6 8.6 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 479 6 2 4 4.1 CCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL220753 84099 None 0 Human Binding pKi = 8.6 8.6 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 479 6 2 4 4.1 CCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
16105895 142005 None 0 Human Binding pKi = 5.7 5.7 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 2 5 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc3cccc(NC(=O)c4ccccc4)c3c2)CC1 10.1021/jm061118e
CHEMBL386987 142005 None 0 Human Binding pKi = 5.7 5.7 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 2 5 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc3cccc(NC(=O)c4ccccc4)c3c2)CC1 10.1021/jm061118e
11563243 168803 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 575 9 2 5 5.7 CCN1CCC(C(=O)NC2(C(=O)O)CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL436753 168803 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 575 9 2 5 5.7 CCN1CCC(C(=O)NC2(C(=O)O)CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
11270007 84634 None 0 Human Binding pKi = 6.6 6.6 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 416 6 2 3 4.6 O=C(Nc1ccc(S(=O)(=O)NCc2ccccc2)c2ccccc12)c1ccccc1 10.1021/jm061118e
CHEMBL222111 84634 None 0 Human Binding pKi = 6.6 6.6 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 416 6 2 3 4.6 O=C(Nc1ccc(S(=O)(=O)NCc2ccccc2)c2ccccc12)c1ccccc1 10.1021/jm061118e
16105888 136461 None 0 Human Binding pKi = 6.6 6.6 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 466 5 3 4 3.2 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(N)=O)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL373504 136461 None 0 Human Binding pKi = 6.6 6.6 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 466 5 3 4 3.2 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(N)=O)CC2)c2ccccc12 10.1021/jm061118e
11541073 76017 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 532 8 1 4 7.1 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccc(Cl)cc4)CCCCC3)CC2)c1 10.1021/jm050965z
CHEMBL205457 76017 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 532 8 1 4 7.1 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccc(Cl)cc4)CCCCC3)CC2)c1 10.1021/jm050965z
11539239 78155 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 430 8 1 4 4.8 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)Cc3ccccc3)CC2)c1 10.1021/jm050965z
CHEMBL210322 78155 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 430 8 1 4 4.8 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)Cc3ccccc3)CC2)c1 10.1021/jm050965z
792361 76218 None 4 Human Binding pKi = 5.6 5.6 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 339 6 0 4 4.3 CCOC(=O)C1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
CHEMBL205808 76218 None 4 Human Binding pKi = 5.6 5.6 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 339 6 0 4 4.3 CCOC(=O)C1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
11584004 140785 None 1 Human Binding pKi = 7.6 7.6 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 489 7 2 4 5.1 O=C(NC1CCN(Cc2cccc(Oc3ccccc3Cl)c2)CC1)C1(c2ccccc2)CCNC1 10.1021/jm050965z
CHEMBL381619 140785 None 1 Human Binding pKi = 7.6 7.6 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 489 7 2 4 5.1 O=C(NC1CCN(Cc2cccc(Oc3ccccc3Cl)c2)CC1)C1(c2ccccc2)CCNC1 10.1021/jm050965z
16105891 84285 None 0 Human Binding pKi = 8.5 8.5 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 506 5 2 4 4.0 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221130 84285 None 0 Human Binding pKi = 8.5 8.5 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 506 5 2 4 4.0 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCC3)CC2)c2ccccc12 10.1021/jm061118e
44419035 84315 None 0 Human Binding pKi = 7.5 7.5 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 9 2 5 4.8 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NCCCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221345 84315 None 0 Human Binding pKi = 7.5 7.5 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 9 2 5 4.8 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NCCCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
11384528 141719 None 0 Human Binding pKi = 5.5 5.5 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 417 6 2 4 4.0 O=C(Nc1ccc(S(=O)(=O)NCc2ccncc2)c2ccccc12)c1ccccc1 10.1021/jm061118e
CHEMBL385287 141719 None 0 Human Binding pKi = 5.5 5.5 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 417 6 2 4 4.0 O=C(Nc1ccc(S(=O)(=O)NCc2ccncc2)c2ccccc12)c1ccccc1 10.1021/jm061118e
16105832 83393 None 0 Human Binding pKi = 7.5 7.5 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 479 7 2 4 4.1 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)C1 10.1021/jm061118e
CHEMBL219327 83393 None 0 Human Binding pKi = 7.5 7.5 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 479 7 2 4 4.1 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)C1 10.1021/jm061118e
44419032 84591 None 0 Human Binding pKi = 7.5 7.5 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 8 2 5 4.4 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NCCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL222058 84591 None 0 Human Binding pKi = 7.5 7.5 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 8 2 5 4.4 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NCCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
16105840 84393 None 0 Human Binding pKi = 7.4 7.4 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 468 7 1 5 4.3 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(OCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221789 84393 None 0 Human Binding pKi = 7.4 7.4 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 468 7 1 5 4.3 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(OCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
10254576 84410 None 0 Human Binding pKi = 8.4 8.4 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 480 6 3 5 2.6 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CN)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221904 84410 None 0 Human Binding pKi = 8.4 8.4 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 480 6 3 5 2.6 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CN)CC2)c2ccccc12 10.1021/jm061118e
16105824 84304 None 0 Human Binding pKi = 8.4 8.4 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 549 5 2 5 3.5 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCN(C)CC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221251 84304 None 0 Human Binding pKi = 8.4 8.4 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 549 5 2 5 3.5 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCN(C)CC3)CC2)c2ccccc12 10.1021/jm061118e
16105892 141694 None 0 Human Binding pKi = 8.4 8.4 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 534 5 2 4 4.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCCCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL385108 141694 None 0 Human Binding pKi = 8.4 8.4 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 534 5 2 4 4.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCCCC3)CC2)c2ccccc12 10.1021/jm061118e
11452569 83233 None 0 Human Binding pKi = 8.4 8.4 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 408 5 2 3 4.7 O=C(Nc1ccc(S(=O)(=O)NC2CCCCC2)c2ccccc12)c1ccccc1 10.1021/jm061118e
CHEMBL218503 83233 None 0 Human Binding pKi = 8.4 8.4 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 408 5 2 3 4.7 O=C(Nc1ccc(S(=O)(=O)NC2CCCCC2)c2ccccc12)c1ccccc1 10.1021/jm061118e
3384970 161375 None 6 Human Binding pKi = 7.4 7.4 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 432 6 2 4 4.9 COc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)cc1 10.1021/jm061118e
CHEMBL412116 161375 None 6 Human Binding pKi = 7.4 7.4 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 432 6 2 4 4.9 COc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)cc1 10.1021/jm061118e
44419031 137789 None 0 Human Binding pKi = 7.3 7.3 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 467 7 2 5 4.4 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL375880 137789 None 0 Human Binding pKi = 7.3 7.3 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 467 7 2 5 4.4 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
10391077 137471 None 0 Human Binding pKi = 8.3 8.3 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 6 2 5 4.3 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(C(=O)Nc3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL375315 137471 None 0 Human Binding pKi = 8.3 8.3 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 6 2 5 4.3 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(C(=O)Nc3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
16105877 82856 None 0 Human Binding pKi = 8.3 8.3 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 3 5 2.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CO)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL218036 82856 None 0 Human Binding pKi = 8.3 8.3 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 3 5 2.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CO)CC2)c2ccccc12 10.1021/jm061118e
16105844 82803 None 0 Human Binding pKi = 7.3 7.3 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 465 7 2 4 3.7 CCCC(=O)N1CC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)C1 10.1021/jm061118e
CHEMBL217979 82803 None 0 Human Binding pKi = 7.3 7.3 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 465 7 2 4 3.7 CCCC(=O)N1CC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)C1 10.1021/jm061118e
16105830 83430 None 0 Human Binding pKi = 6.3 6.3 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 564 11 2 5 4.8 CCN(CC)CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL219487 83430 None 0 Human Binding pKi = 6.3 6.3 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 564 11 2 5 4.8 CCN(CC)CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
11235229 83445 None 0 Human Binding pKi = 6.2 6.2 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 409 5 3 4 3.1 O=C(Nc1ccc(S(=O)(=O)NC2CCNCC2)c2ccccc12)c1ccccc1 10.1021/jm061118e
CHEMBL219588 83445 None 0 Human Binding pKi = 6.2 6.2 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 409 5 3 4 3.1 O=C(Nc1ccc(S(=O)(=O)NC2CCNCC2)c2ccccc12)c1ccccc1 10.1021/jm061118e
11541506 76543 None 0 Human Binding pKi = 8.2 8.2 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 575 9 2 5 5.7 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)C1 10.1021/jm050965z
CHEMBL205993 76543 None 0 Human Binding pKi = 8.2 8.2 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 575 9 2 5 5.7 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)C1 10.1021/jm050965z
16105893 83179 None 0 Human Binding pKi = 8.2 8.2 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 536 5 2 5 3.6 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCOCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL218218 83179 None 0 Human Binding pKi = 8.2 8.2 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 536 5 2 5 3.6 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCOCC3)CC2)c2ccccc12 10.1021/jm061118e
16105803 84443 None 0 Human Binding pKi = 8.2 8.2 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 465 5 2 4 3.7 CC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221977 84443 None 0 Human Binding pKi = 8.2 8.2 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 465 5 2 4 3.7 CC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
11706579 139824 None 0 Human Binding pKi = 7.2 7.2 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 543 9 3 6 4.3 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)(C(=O)O)CC2)c1 10.1021/jm050965z
CHEMBL379834 139824 None 0 Human Binding pKi = 7.2 7.2 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 543 9 3 6 4.3 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)(C(=O)O)CC2)c1 10.1021/jm050965z
11533398 76013 None 0 Human Binding pKi = 7.2 7.2 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 499 8 2 5 4.9 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)CC2)c1 10.1021/jm050965z
CHEMBL205447 76013 None 0 Human Binding pKi = 7.2 7.2 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 499 8 2 5 4.9 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)CC2)c1 10.1021/jm050965z
16105876 137291 None 0 Human Binding pKi = 8.1 8.1 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 491 6 2 4 4.1 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C3CC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL374979 137291 None 0 Human Binding pKi = 8.1 8.1 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 491 6 2 4 4.1 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C3CC3)CC2)c2ccccc12 10.1021/jm061118e
16105826 83208 None 0 Human Binding pKi = 7.2 7.2 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 578 9 2 6 3.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCCN3CCOCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL218366 83208 None 0 Human Binding pKi = 7.2 7.2 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 578 9 2 6 3.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCCN3CCOCC3)CC2)c2ccccc12 10.1021/jm061118e
16105820 141720 None 0 Human Binding pKi = 7.1 7.1 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 508 7 3 4 4.3 CCCNC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL385288 141720 None 0 Human Binding pKi = 7.1 7.1 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 508 7 3 4 4.3 CCCNC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
16105821 83204 None 0 Human Binding pKi = 7.1 7.1 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 508 6 3 4 4.3 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)NC(C)C)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL218350 83204 None 0 Human Binding pKi = 7.1 7.1 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 508 6 3 4 4.3 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)NC(C)C)CC2)c2ccccc12 10.1021/jm061118e
1099153 83174 None 6 Human Binding pKi = 5.1 5.1 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 396 4 1 4 3.1 O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)c2ccccc12)c1ccccc1 10.1021/jm061118e
CHEMBL218207 83174 None 6 Human Binding pKi = 5.1 5.1 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 396 4 1 4 3.1 O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)c2ccccc12)c1ccccc1 10.1021/jm061118e
16105882 142082 None 0 Human Binding pKi = 7.1 7.1 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 527 6 2 4 5.0 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)c3ccccc3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL387451 142082 None 0 Human Binding pKi = 7.1 7.1 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 527 6 2 4 5.0 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)c3ccccc3)CC2)c2ccccc12 10.1021/jm061118e
11685733 140289 None 0 Human Binding pKi = 8.1 8.1 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 589 9 2 5 6.1 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL380492 140289 None 0 Human Binding pKi = 8.1 8.1 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 589 9 2 5 6.1 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
16105804 83422 None 0 Human Binding pKi = 8.0 8.0 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 519 6 2 4 4.9 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C3CCCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL219433 83422 None 0 Human Binding pKi = 8.0 8.0 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 519 6 2 4 4.9 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C3CCCC3)CC2)c2ccccc12 10.1021/jm061118e
11329260 84273 None 0 Human Binding pKi = 8.0 8.0 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 487 6 2 5 3.8 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(C(=O)NC3CCCCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221021 84273 None 0 Human Binding pKi = 8.0 8.0 - 1
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 487 6 2 5 3.8 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(C(=O)NC3CCCCC3)c3ccccc23)CC1 10.1021/jm061118e
11530171 75997 None 0 Human Binding pKi = 5.0 5.0 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 338 6 1 3 3.8 CCNC(=O)C1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
CHEMBL205304 75997 None 0 Human Binding pKi = 5.0 5.0 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 338 6 1 3 3.8 CCNC(=O)C1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
11681610 140672 None 0 Human Binding pKi = 5.0 5.0 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 338 6 1 3 4.0 CCC(=O)NC1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
CHEMBL381354 140672 None 0 Human Binding pKi = 5.0 5.0 - 1
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 338 6 1 3 4.0 CCC(=O)NC1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z